...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Sabizabulin - mCRPC- used now for Covid 19.
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Unless Zenith was to get a new, competent, CEO my hope would just be for an outright sale of the company. I don't think we would see close to fair value on an IPO based on a licensing model managed by leadership that has not been able to create value from previous opportunity. JMO

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply